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Tertiary care centres must do more for patients with unknown conditions:
Lessons learned from a child
Guido Filler, MD, PhD, University of Western Ontario, Guido.Filler@lhsc.on.ca
Lana Rothfels, BA, Sc, University of Western Ontario, lrothfels2020@meds.uwo.ca
Abstract
Postural Orthostatic Tachycardia Syndrome (POTS) is a debilitating disease with a commonly non-uniform and
unspecific presentation that makes diagnosis difficult. A twelve-year-old girl, recently diagnosed with Addison’s Disease,
was referred to paediatric nephrology for Fludrocortisone-induced nocturnal hypertension. She had fallen off the growth
curve for both height and weight from the 50th percentile at birth to below the 5th percentile at presentation. The
severity and multitude of her symptoms, including muscle weakness, poor body control, dizziness, light headedness,
persistent fatigue, excessive sweating, tachycardia, chronic constipation and recurrent infection hinted at the unusual
nature of this case of Addison’s. At the time of referral, she had been seen by more than a dozen specialists and
subspecialists as well as undergone a number of tests including neurophysiological testing without sufficient explanation.
With the help of tilt-table testing, we established the diagnosis of POTS. There is a lack of tested treatment options for
POTS, and we established dosing of pyridostigmine in children, based on the emerging literature in adults. While
pyridostigmine therapy substantially improved her quality of life, it took another 6 years and referral outside the country,
before a final unifying diagnosis was made. Eventually, the patient was diagnosed with Ehlers Danlos Syndrome with
associated autonomic dysfunction, including POTS, as well as primary adrenal insufficiency. The parents and the patient
experienced considerable stress due to the lack of willingness of many physicians that the family encountered to search
for a diagnosis and a treatment.
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Intent of this Essay
“About 8% of Canadians, or 3 million individuals, have a
rare disease. Nearly two-thirds of those with rare diseases
are children. Canadians have benefitted from public health
strategies in diabetes, cancer, heart disease and mental
illness whereas the approach to rare diseases has remained
fragmented across the country. As a result, Canadian
families with rare illnesses face extraordinary challenges,
including misdiagnoses, unnecessary surgeries, social
isolation, financial hardship, lack of treatment options and
early death.”1 (Canadian Organization for Rare Disorders)
Unfortunately, the experience of pediatric patients with
undiagnosed rare diseases remains unfavorable owing to
the compartmentalized approach inherent to our
subspecialized system. We present a case of complex
autonomic dysfunction affecting multiple organ systems
and leading to debilitating limitations of day-to-day living
that caused an odyssey through the Tertiary Healthcare
System and out-of-country referrals before a unifying
diagnosis and the best possible treatment was found. The
purpose is to showcase in this situation that the diagnostic

workup can be improved and years of meandering through
the health care system can be avoided.

General Narrative
Our patient is one of the three million individuals in
Canada inflicted with the misfortune of having a rare
disease. Born with chronic constipation and plagued with
recurrent infection and persistent fatigue, the patient and
her family started on what would prove to be an
exhaustingly long quest for answers. At the time of
referral, she had already been seen by more than a dozen
specialists and subspecialists as well as undergone a
number of tests including neurophysiological testing
without a clear diagnosis. As a result of several ER
admissions for severe bronchitis and pneumonia she was
labeled with incorrect diagnoses. When seen by GI for her
chronic constipation, it was suggested she undergo a
bowel resection, which her parents fortunately refused.
They believed there was a root cause to all of her suffering
and were determined to find it.
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At twelve years of age, the patient was referred to
paediatric nephrology for Fludrocortisone-induced
nocturnal hypertension, after having been diagnosed by
her second paediatric endocrinologist with Addison’s
Disease. By age twelve, she had fallen off the growth curve
for both height and weight from the 50th percentile at birth
to below the 5th percentile (Figure 1). The onset of

Addison’s Disease was most likely congenital, but
diagnosis was delayed due to her lack of
hyperpigmentation, though this symptom may only be
present in 55% of patients.2 While this initial diagnosis
explained some of her presentation, the severity and
multitude of her symptoms, including muscle weakness,
poor body control, dizziness, light headedness, persistent

Figure 1. Height and weight of our patient against the reference intervals of the Center of Disease Control
(https://www.cdc.gov/growthcharts/clinical_charts.htm). The target height based on the mid-parental height and
adjustment for girls was 163 ±10 cm
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fatigue, excessive sweating, and tachycardia, as well as joint
hypermobility and excessive dorsiflexion of her fingers
suggested that this was not a typical case of Addison's
Disease. The discordance between the severity of her
symptoms and the availability of objective findings
characteristic of autonomic dysfunction made for a
difficult diagnosis, thus our patient was continually passed
from specialist to specialist as each one exhausted the
boundaries of their practice.
Eventually, repeated tilt table testing revealed a postural
heart rate of up to 200 beats per minute, and the diagnosis
of Postural Orthostatic Tachycardia Syndrome (POTS)
was assigned; however, it took another 6 years and
referrals to Dr. Peter Rowe (Johns Hopkins) and Dr. Blair
Grubb (Toledo, both U.S.A), before a final unifying
diagnosis was made. Eventually, our patient was diagnosed
with Ehlers Danlos Syndrome with associated autonomic
dysfunction, including POTS, as well as cortisol deficiency.
It is not uncommon for Ehlers Danlos syndrome to be
associated with autonomic dysfunction,3 nor
gastrointestinal manifestations.4 In a recent study, 48.6%
of Ehlers Danlos syndrome patients had postural
orthostatic tachycardia, 31.4% had orthostatic intolerance
and only 20% had normal results.3 Unfortunately, there are
11 known types of Ehlers Danlos syndrome, and often the
classic features of type I (gravis form) are absent. Some
authors now consider the association of Ehlers Danlos
syndrome and autonomous dysfunction a distinct
subtype.5
After the diagnosis was made, several treatments including
salt supplements, high fluid intake and Fludrocortisone,
were tried. Initially, this significantly reduced her
symptoms, but they recurred within a matter of months.
Additional treatment attempts with both clonidine and
Midodrine were abandoned due of severe side effects. The
patient’s dose of Fludrocortisone was gradually increased,
as without it her baseline daytime blood pressure would
drop to 70/40 mm Hg (50th percentile for a height of 140
cm 103/60 mm Hg, 5th percentile 85/41 mm Hg).6
This eventually led to the development supine/nocturnal
hypertension as a side effect of Fludrocortisone, so she
started on anti-hypertensives at night. At this point,
Pyridostigmine had been investigated for off-label use in
adult POTS patients, but no dosing recommendations
existed for children and the pharmacokinetics had not
been studied. To facilitate the trial of this treatment, we
therefore developed a test for pharmacokinetic monitoring
using a newly developed semi-automated and specific
high-performance liquid chromatography/tandem mass
spectrometry assay and established normal
pharmacokinetics for children with myasthenia gravis, and
then applied the learnings to the patient.7 A dose of 60 mg
resulted in a substantial decrease in the initial tachycardia
response to upright tilt that persisted in the plateau phase.
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To accommodate the rapid metabolism during childhood,
the patient received 3 doses over the day with a substantial
improvement in the quality of life.
Today, at the age of 28, our patient is unrecognizable from
the frail little girl that walked into our office 15 years ago.
After completing a Masters and Ph.D. in Physics, she is
now working as a Post Doc at a major American
university. With the aid of compression stockings and a
compression suit, she was able to successfully travel to
present her Ph.D. research around the globe. She regularly
walks over 2 kilometers per day thanks to physiotherapy
and custom orthotics – a huge improvement from the pain
that exercise used to cause her.

Reflections/Recommendations Based on
Experience
Throughout this process, apart from the suffering of the
patient, the family experienced considerable stress due to
the lack of willingness of many physicians working within
the framework of a fragmented system to search for an
appropriate diagnosis that would allow for necessary
treatment. The family expressed that “So many of the
physicians we met specialized in a small number of
conditions and once they ruled those out, were not the
least concerned about finding the cause of the patient’s
problems and treating them. This speaks to each specialist
working in their own silo with no overall owner of [our
daughter’s] file. The worst part [of our experience] is that
there is no way to report these kinds of mistakes to the
system constructively to ensure that the doctors do not
continue to repeat the same mistakes.” These remarks
illustrate the severity of the disheartening stress endured
by the families of paediatric patients with rare and
unknown diseases in a system limited by the imposition of
stark and specific boundaries of individual specialists.
Unfortunately, this “diagnostic odyssey” that patients and
families with rare disorders undergo is actually quite well
established in the rare disease literature.8 A survey of such
patients demonstrated that for 25% of participants the
time to diagnosis was extensive, ranging from 5-30 years,
and during that time, 40% received an incorrect diagnosis,
while 50% never received a diagnosis.8 Recently, several
consortia have advocated the idea that earlier institution of
whole genome or whole exome sequencing might reduce
the odyssey by years.9
This patient’s positive outcome would have been
impossible without this family's perseverance on their long
search for answers. Unfortunately, not all families are so
resourceful. Autonomic dysfunction is understudied and
under-taught, and centers for autonomic dysfunction are
only now starting to emerge in Canada, at this point only
for adult patients.10
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Academic health sciences centres are the last frontier for
undiagnosed diseases; the last hope for patients that have
often been through so much despair. We are fortunate to
work in a country where the governments of the provinces
acknowledge the need for such research and allow and
remunerate for a proportion of scholarly activities to help
patients like ours. Thus, it is our duty to our patients to
utilize all resources at our disposal for diagnosis and
treatment. We must not accept the failure to diagnose
patients with rare diseases. Once we have diagnosed, we
must not let a lack of tested treatment options resign us to
inaction. We must not back away from these challenges,
but instead take the time as doctors to search within a
much broader framework for the answers our patients
need. The rewards for doing so, as this patient has taught
us, can be incredible.

10. UToday.
https://www.ucalgary.ca/utoday/issue/2015-1022/first-autonomic-nervous-system-disorder-clinicopens-calgary. 2015.
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